Viewing Study NCT06983158


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2026-05-27 @ 12:09 PM
Study NCT ID: NCT06983158
Status: SUSPENDED
Last Update Posted: 2025-10-01
First Post: 2025-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy
Sponsor: Capsida Biotherapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Developmental and Epileptic Encephalopathy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None STXBP1 View
None Gene therapy View